All posts tagged: Philadelphia District Attorney’s Office

Jake Tapper: Finally, Justice for C. J. Rice

[ad_1] C. J. Rice was first arraigned in 2011 on the 11th floor of 1301 Filbert Street, a towering, steel-framed criminal-court complex two miles from the South Philadelphia neighborhood where he’d grown up. In 2013, on the fifth floor of the same building, Rice was tried on four counts of attempted murder, found guilty, and sentenced to 30 to 60 years in prison. For three years, he appealed the sentence, appearing on the sixth, seventh, eighth, ninth, and tenth floors. After each attempt failed, he was shuttled back to a state prison in rural Coal Township, Pennsylvania. This morning, on the eighth floor, the Philadelphia District Attorney’s Office announced that it no longer considers Rice a viable suspect in the shooting for which he had been found guilty. His conviction had already been overturned by a federal court in November, on the grounds that his attorney had been constitutionally deficient. In today’s decision, the D.A.’s office formally dismissed the charges against him. The D.A.’s decision fully exonerates Rice. He is now a free man. He …

A Breakthrough in Gene Editing

[ad_1] This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. I spoke with my colleague Sarah Zhang about a breakthrough in CRISPR therapy, and when it is ethical to use the gene-editing technology. First, here are three new stories from The Atlantic: A Transformative Treatment Earlier this month, U.K. regulators approved a new therapy that uses CRISPR—a gene-editing technology that allows scientists to make cuts to DNA—to treat people with sickle-cell disease. FDA approval is likely in the coming weeks. I spoke with my colleague Sarah Zhang, who has been covering CRISPR for more than a decade, about this landmark treatment, ethical use of the technology, and what fair access to CRISPR therapy could look like in the future. Lora Kelley: What makes sickle-cell disease an obvious match for CRISPR therapy? Sarah Zhang: As soon as scientists started talking about what we can do with CRISPR, treating sickle …